Skip to main content

Advertisement

Log in

The carrageenan controversy

  • 22ND INTERNATIONAL SEAWEED SYMPOSIUM, COPENHAGEN
  • Published:
Journal of Applied Phycology Aims and scope Submit manuscript

Abstract

Except for Japanese nori, the production of seaweed hydrocolloids consumes the largest amount of macroalgae annually, and carrageenan is the largest consumer of this group. However, carrageenan has run into rough water with food processors and consumers, especially those who read ingredient labels. Carrageenan is being singled out on the Internet as being unsafe for human consumption, even though it is approved for food use by all major food regulatory agencies worldwide. Most recently, it has been approved for use in liquid infant formula, a particularly sensitive application when it comes to food safety. How did this negative attitude toward carrageenan evolve? It can be traced to a research group at the University of Illinois who claim that carrageenan upregulates inflammatory genes of the intestinal epithelium. There is no evidence that this in vitro model applies in vivo and a growing body of research is showing it does not. Nevertheless, it was picked up by various bloggers feeding on contradictory issues and quickly went viral. This paper describes the evolution of the “carrageenan controversy” and provides information for food producers and consumers on new more robust studies confirming that it is safe to consume foods containing carrageenan. This article also presents actions being taken by carrageenan producers and users, to reduce the noise in the public domain from the controversy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Download references

Acknowledgements

The author wishes to offer his most sincere thanks to Ms. Deborah Young for her work on the references that came from sources not usually found in this journal.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harris J. Bixler.

Ethics declarations

Disclaimer

The author has spent 48 years in the carrageenan industry in capacities ranging from R&D Director, President, Company Owner and Consultant. He is also an active member of Marinalg and IFAC.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bixler, H.J. The carrageenan controversy. J Appl Phycol 29, 2201–2207 (2017). https://doi.org/10.1007/s10811-017-1132-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10811-017-1132-4

Keywords

Navigation